🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sjögren's syndrome is a condition in which the immune system attacks the bo...
Status
Not Yet Recruiting
Location
Instituto de Oftalmología Conde de Valenciana
Start Date
2026-12
Trial ID
NCT07671222
Treatments Being Tested
This study is being conducted to compare the safety and efficacy of lotepre...
Status
Completed
Location
Bausch & Lomb, Inc.
Start Date
2009-11
Trial ID
NCT01010633
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of lotep...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2014-09
Trial ID
NCT02208297
Treatments Being Tested
Loteprednol Etabonate Ophthalmic Gel, (BID and TID) versus Vehicle Group fo...
Status
Completed
Location
Valeant Site 01
Start Date
2016-06
Trial ID
NCT02786901
The primary purpose of this study is to determine the efficacy and safety o...
Status
Completed
Location
Cornea and Cataract Consultants of Arizona
Start Date
2016-06
Trial ID
NCT02813265
Treatments Being Tested
Inflammation occurs after any type of incisional surgery. This study will e...
Status
Withdrawn
Location
Shiley Eye Center
Start Date
2012-09
Trial ID
NCT01749241
Treatments Being Tested
The primary purpose of this study is to determine the efficacy and safety o...
Status
Completed
Location
Sall Research Medical Center
Start Date
2014-05
Trial ID
NCT02163824
Treatments Being Tested
The objective of this study is to evaluate the safety and effectiveness of ...
Status
Completed
Location
Pediatric Ophthalmology of Erie
Start Date
2008-06
Trial ID
NCT00705159
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of loteprednol etabon...
Status
Completed
Location
Bausch & Lomb
Start Date
2010-04
Trial ID
NCT01107405
The CLEAN Study: Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Se...
Status
Completed
Location
Inland Eye Specialists
Start Date
2022-06-03
Trial ID
NCT05322148
Treatments Being Tested